JPH10114649A - 津液改善剤及びそれを含有する経口投与用組成物 - Google Patents
津液改善剤及びそれを含有する経口投与用組成物Info
- Publication number
- JPH10114649A JPH10114649A JP8272727A JP27272796A JPH10114649A JP H10114649 A JPH10114649 A JP H10114649A JP 8272727 A JP8272727 A JP 8272727A JP 27272796 A JP27272796 A JP 27272796A JP H10114649 A JPH10114649 A JP H10114649A
- Authority
- JP
- Japan
- Prior art keywords
- action
- group
- represented
- general formula
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims description 29
- 210000001124 body fluid Anatomy 0.000 title abstract 3
- 239000010839 body fluid Substances 0.000 title abstract 3
- 230000009471 action Effects 0.000 claims abstract description 50
- 206010012438 Dermatitis atopic Diseases 0.000 claims abstract description 16
- 201000008937 atopic dermatitis Diseases 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 9
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 8
- HUJXHFRXWWGYQH-UHFFFAOYSA-O sinapine Chemical compound COC1=CC(\C=C\C(=O)OCC[N+](C)(C)C)=CC(OC)=C1O HUJXHFRXWWGYQH-UHFFFAOYSA-O 0.000 claims abstract description 8
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims abstract description 5
- 235000017663 capsaicin Nutrition 0.000 claims abstract description 5
- 229960002504 capsaicin Drugs 0.000 claims abstract description 5
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 4
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 235000012754 curcumin Nutrition 0.000 claims abstract description 4
- 229940109262 curcumin Drugs 0.000 claims abstract description 4
- 239000004148 curcumin Substances 0.000 claims abstract description 4
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000028327 secretion Effects 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 22
- 201000004624 Dermatitis Diseases 0.000 claims description 20
- 230000003779 hair growth Effects 0.000 claims description 16
- 230000001079 digestive effect Effects 0.000 claims description 10
- 208000007163 Dermatomycoses Diseases 0.000 claims description 9
- 201000004681 Psoriasis Diseases 0.000 claims description 9
- 206010039796 Seborrhoeic keratosis Diseases 0.000 claims description 9
- 201000003929 dermatomycosis Diseases 0.000 claims description 9
- 230000001882 diuretic effect Effects 0.000 claims description 9
- 230000019612 pigmentation Effects 0.000 claims description 9
- 206010048218 Xeroderma Diseases 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 206010021198 ichthyosis Diseases 0.000 claims description 8
- 230000037380 skin damage Effects 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 208000034189 Sclerosis Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 12
- 230000001225 therapeutic effect Effects 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 abstract description 4
- 230000004936 stimulating effect Effects 0.000 abstract description 3
- 230000003248 secreting effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 34
- 208000010668 atopic eczema Diseases 0.000 description 14
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 208000012641 Pigmentation disease Diseases 0.000 description 8
- 208000000260 Warts Diseases 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 201000010153 skin papilloma Diseases 0.000 description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000035900 sweating Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- -1 alkali metal salts Chemical class 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000003636 fecal output Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VWEFYICUFMTXGX-FCXRPNKRSA-N (1e,6e)-1-(4-hydroxy-3-methoxyphenyl)-7-[4-hydroxy-3-(2-oxopropoxy)phenyl]hepta-1,6-diene-3,5-dione Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OCC(C)=O)C(O)=CC=2)=C1 VWEFYICUFMTXGX-FCXRPNKRSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8272727A JPH10114649A (ja) | 1996-10-15 | 1996-10-15 | 津液改善剤及びそれを含有する経口投与用組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8272727A JPH10114649A (ja) | 1996-10-15 | 1996-10-15 | 津液改善剤及びそれを含有する経口投与用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10114649A true JPH10114649A (ja) | 1998-05-06 |
| JPH10114649A5 JPH10114649A5 (enrdf_load_stackoverflow) | 2004-10-14 |
Family
ID=17517946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8272727A Pending JPH10114649A (ja) | 1996-10-15 | 1996-10-15 | 津液改善剤及びそれを含有する経口投与用組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH10114649A (enrdf_load_stackoverflow) |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999044981A1 (fr) * | 1998-03-04 | 1999-09-10 | Morinaga & Co., Ltd. | Nouvelles substances du type capsaicinoide, possedant une liaison ester |
| JP2002205998A (ja) * | 2000-10-20 | 2002-07-23 | Daicho Kikaku:Kk | 栄養剤、消化器剤 |
| JP2002226445A (ja) * | 2001-02-01 | 2002-08-14 | T Hasegawa Co Ltd | トウガラシからのカプサイシノイド様物質の抽出方法 |
| EP1254658A4 (en) * | 2000-01-27 | 2003-06-18 | Takara Bio Inc | DRUGS |
| JP2004182600A (ja) * | 2001-10-31 | 2004-07-02 | Daicho Kikaku:Kk | 皮膚用剤 |
| EP1437117A1 (de) * | 2002-12-19 | 2004-07-14 | Cognis France S.A. | Verwendung von Sinapinsäure und/oder Sinapinsäurederivaten |
| WO2006117077A1 (en) * | 2005-05-03 | 2006-11-09 | Dsm Ip Assets B.V. | Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives |
| JP2006347948A (ja) * | 2005-06-15 | 2006-12-28 | Ryukyu Bio Resource Kaihatsu:Kk | 口腔粘膜用の鎮痛・抗炎症トローチ剤 |
| WO2006116485A3 (en) * | 2005-04-25 | 2007-01-11 | Neurogesx Inc | Trpv1 agonist compounds and methods for making and using the same |
| CN1312106C (zh) * | 2003-03-28 | 2007-04-25 | 烟台同和医药科技有限公司 | 一种水溶性姜黄素复合盐的制备方法 |
| JP2007246470A (ja) * | 2006-03-17 | 2007-09-27 | Daicho Kikaku:Kk | 新しい薬剤 |
| WO2008111271A1 (ja) * | 2007-03-15 | 2008-09-18 | Kaigen Co., Ltd. | 育毛・発毛用経口組成物 |
| WO2011023342A1 (en) | 2009-08-25 | 2011-03-03 | Sns Nano Fiber Technology, Llc | Textile composite material for decontaminating the skin |
| JP4764518B1 (ja) * | 2010-07-28 | 2011-09-07 | 株式会社 資生堂 | 経口毛穴改善剤 |
| WO2012023996A1 (en) | 2010-08-20 | 2012-02-23 | Sns Nano Fiber Technology, Llc | Textile composite material comprising nanofiber nonwoven |
| JP2012193201A (ja) * | 2012-07-11 | 2012-10-11 | Daicho Kikaku:Kk | 消化器不全治療剤 |
| JP2012193203A (ja) * | 2012-07-11 | 2012-10-11 | Daicho Kikaku:Kk | 栄養剤 |
| JP2012193202A (ja) * | 2012-07-11 | 2012-10-11 | Daicho Kikaku:Kk | 消化器不全治療剤 |
| JP2012193200A (ja) * | 2001-10-31 | 2012-10-11 | Daicho Kikaku:Kk | 皮膚用剤 |
| JP2014198734A (ja) * | 2014-07-28 | 2014-10-23 | 有限会社大長企画 | 動物用消化器不全治療剤 |
| JP2014198735A (ja) * | 2014-07-28 | 2014-10-23 | 有限会社大長企画 | 動物用栄養剤 |
| JP2014221822A (ja) * | 2014-07-28 | 2014-11-27 | 有限会社大長企画 | 動物用消化器不全治療剤 |
-
1996
- 1996-10-15 JP JP8272727A patent/JPH10114649A/ja active Pending
Cited By (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999044981A1 (fr) * | 1998-03-04 | 1999-09-10 | Morinaga & Co., Ltd. | Nouvelles substances du type capsaicinoide, possedant une liaison ester |
| US7268160B2 (en) | 2000-01-27 | 2007-09-11 | Takara Bio, Inc. | Remedies |
| EP1254658A4 (en) * | 2000-01-27 | 2003-06-18 | Takara Bio Inc | DRUGS |
| JP2002205998A (ja) * | 2000-10-20 | 2002-07-23 | Daicho Kikaku:Kk | 栄養剤、消化器剤 |
| JP2002226445A (ja) * | 2001-02-01 | 2002-08-14 | T Hasegawa Co Ltd | トウガラシからのカプサイシノイド様物質の抽出方法 |
| JP2004182600A (ja) * | 2001-10-31 | 2004-07-02 | Daicho Kikaku:Kk | 皮膚用剤 |
| JP2012193200A (ja) * | 2001-10-31 | 2012-10-11 | Daicho Kikaku:Kk | 皮膚用剤 |
| JP2014208697A (ja) * | 2001-10-31 | 2014-11-06 | 有限会社大長企画 | 動物用皮膚用剤 |
| EP1437117A1 (de) * | 2002-12-19 | 2004-07-14 | Cognis France S.A. | Verwendung von Sinapinsäure und/oder Sinapinsäurederivaten |
| CN1312106C (zh) * | 2003-03-28 | 2007-04-25 | 烟台同和医药科技有限公司 | 一种水溶性姜黄素复合盐的制备方法 |
| WO2006116485A3 (en) * | 2005-04-25 | 2007-01-11 | Neurogesx Inc | Trpv1 agonist compounds and methods for making and using the same |
| JP2008539253A (ja) * | 2005-04-25 | 2008-11-13 | ニューロジェシックス， インコーポレイテッド | Ｔｒｐｖ１アゴニスト化合物、ならびにｔｒｐｖ１アゴニスト化合物を製造および使用するための方法 |
| US7632519B2 (en) | 2005-04-25 | 2009-12-15 | Neurogesx, Inc. | TRPV1 agonist compounds, formulations, prodrugs, methods for using the same |
| WO2006117077A1 (en) * | 2005-05-03 | 2006-11-09 | Dsm Ip Assets B.V. | Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives |
| JP2006347948A (ja) * | 2005-06-15 | 2006-12-28 | Ryukyu Bio Resource Kaihatsu:Kk | 口腔粘膜用の鎮痛・抗炎症トローチ剤 |
| JP2007246470A (ja) * | 2006-03-17 | 2007-09-27 | Daicho Kikaku:Kk | 新しい薬剤 |
| WO2008111271A1 (ja) * | 2007-03-15 | 2008-09-18 | Kaigen Co., Ltd. | 育毛・発毛用経口組成物 |
| WO2011023342A1 (en) | 2009-08-25 | 2011-03-03 | Sns Nano Fiber Technology, Llc | Textile composite material for decontaminating the skin |
| JP4764518B1 (ja) * | 2010-07-28 | 2011-09-07 | 株式会社 資生堂 | 経口毛穴改善剤 |
| WO2012023996A1 (en) | 2010-08-20 | 2012-02-23 | Sns Nano Fiber Technology, Llc | Textile composite material comprising nanofiber nonwoven |
| JP2012193201A (ja) * | 2012-07-11 | 2012-10-11 | Daicho Kikaku:Kk | 消化器不全治療剤 |
| JP2012193203A (ja) * | 2012-07-11 | 2012-10-11 | Daicho Kikaku:Kk | 栄養剤 |
| JP2012193202A (ja) * | 2012-07-11 | 2012-10-11 | Daicho Kikaku:Kk | 消化器不全治療剤 |
| JP2014198734A (ja) * | 2014-07-28 | 2014-10-23 | 有限会社大長企画 | 動物用消化器不全治療剤 |
| JP2014198735A (ja) * | 2014-07-28 | 2014-10-23 | 有限会社大長企画 | 動物用栄養剤 |
| JP2014221822A (ja) * | 2014-07-28 | 2014-11-27 | 有限会社大長企画 | 動物用消化器不全治療剤 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH10114649A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| DE69901396T2 (de) | Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäure | |
| JP2002538106A (ja) | イソバレルアミド、イソ吉草酸、または関連化合物を用いてｃｎｓ活性の調節に影響を与えることによる、痙縮および痙攣を含む様々な病状の治療 | |
| JP2002538106A5 (enrdf_load_stackoverflow) | ||
| JP2001064192A (ja) | ランゲルハンス細胞の遊走抑制剤及び抗原提示抑制剤 | |
| Goodhart et al. | Effects of vitamin B (B1) therapy on the polyneuritis of alcohol addicts | |
| JP2000504035A (ja) | イソ吉草酸ｃｎｓ抑制剤による痙縮、痙攣の治療 | |
| JP2018177739A (ja) | Ｔｒｐａ１活性化剤 | |
| RU2114630C1 (ru) | Антидиабетическое средство "самсар" | |
| CN103445175B (zh) | 具有解酒保肝作用的组合物 | |
| JPH10114665A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| JPH10120579A (ja) | 津液改善用皮膚外用剤 | |
| JP4049406B2 (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| JPH10120558A (ja) | 津液改善用皮膚外用剤 | |
| JPH10175859A (ja) | 津液改善用皮膚外用剤 | |
| JPH10175854A (ja) | 津液改善用皮膚外用剤 | |
| JPH10175852A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| JPH10120556A (ja) | 津液改善用皮膚外用剤 | |
| JPH10114652A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| JPH10175860A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| KR20090131577A (ko) | 글루코사민과 생약재 혼합물을 포함하는 약학 제제 | |
| KR100486961B1 (ko) | 성기능 강화에 효과적인 건강보조식품 및 이의 제조방법 | |
| JPH10120561A (ja) | 津液改善用皮膚外用剤 | |
| DE2759108A1 (de) | Verwendung von alpha -mercapto-beta- aryl-acrylsaeuren bei der steigerung des zinkgehaltes im serum und im gewebe | |
| KR20080009695A (ko) | 연골대사 이상질환 개선용 건강식품 및 의약품 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070626 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070628 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20071023 |